Medikamente

ZORA Publikationsliste

Publikationen

• Gouzoulis-Mayfrank, Euphrosyne; Majic, Tomislav; Schaub, Michael P (2025). Stimulanzien vom Amphetamin-Typ In: Batra, Anil; Moggi, Franz; Walter, Marc; Soyka, Michael . Suchtmedizin (2. Auflage). München: Elsevier, 235-256.
• Maier, Larissa J; Haug, Severin; Schaub, Michael P (2016). Author's response on Arria (2016): Intention matters-using the terminology ‘pharmacological neuroenhancement’ as a behavioural definition based on the assumed functionality Addiction, 111(5):938-939.
• Repantis, D; Maier, Larissa J; Heuser, I (2016). Correspondence arising: Modafinil for cognitive neuroenhancement in health non-sleep-deprived-subjects European Neuropsychopharmacology, 26(2):392-393.
• Liakoni, Evangelia; Schaub, Michael P; Maier, Larissa J; Glauser, Gaëlle-Vanessa; Liechti, Matthias E (2015). The Use of Prescription Drugs, Recreational Drugs, and "Soft Enhancers" for Cognitive Enhancement among Swiss Secondary School Students PLoS ONE, 10(10):e0141289.
• Maier, Larissa J; Haug, Severin; Schaub, Michael P (2015). The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students Drug and Alcohol Dependence, 156:221-227.
• Maier, Larissa J; Wunderli, Michael D; Vonmoos, Matthias; Römmelt, Andreas T; Baumgartner, Markus R; Seifritz, Erich; Schaub, Michael P; Quednow, Boris B (2015). Pharmacological cognitive enhancement in healthy individuals: a compensation for cognitive deficits or a question of personality?
• Maier, Larissa J; Schaub, Michael P (2014). „Doping“ am Arbeitsplatz und in der Bildung in der Schweiz Zürich: ISGF.
• Schaub, Michael P; Bachmann, Alwin (2013). Stimulanzien: vielschichtige Konsumphänomene erfordern diversifizierte Angebote SuchtMagazin, 39(3):5-9.
• Rehm, J; Weekes, J (2005). Abuse of controlled prescription drugs In: CCSA . Substance Abuse in Canada: current challenges and choices. Ottawa: Canadian Centre on Substance Abuse, 30-37.
• Frick, Ulrich; Lerch, S; Rehm, Jürgen; Crotti, C (2004). Pilotstudie zur Rezeptierung von Benzodiazepinen in der Schweiz: Beeinflusst die kognitive Verfügbarkeit von Gesetzesvorschriften das ärztliche Verschreibungsverhalten?